English
Deutsch
Italiano
Français
日本語
한국어
Services
NMPA Registration – Medical Devices and IVDs
NMPA Registration & DMF – Pharmaceuticals
NMPA Registration – Cosmetics
NMPA Registration – Health Food
CML (China Manufacture Licence) – Pressure vessels
CCC (China Compulsory Certification) – Industrial and consumer goods
Others
Sourcing and Quality Control
Logistics and Customs Support
Sales Support
Events
Trade Fairs & Conferences
Seminars
Webinars
News & Knowledge
Regulatory News
Medical Devices and IVDs
Cosmetics
Pharmaceuticals & DMF
CCC
Pressure Vessels
Whitepapers
FAQ – NMPA Registration – Medical Devices and IVDs
Newsletter Sign Up
Others
Publications
Online Shop
About us
Partners
Company Profile
Testimonials
Locations
Newsletter Sign Up
Contact
Home
News
NMPA Registration in China
Archive from category "Pharmaceuticals & DMF"
Category: Pharmaceuticals & DMF
0
Cisema - Jacky
Thursday, 30 March 2023
/
Published in
News
,
NMPA Registration in China
,
Pharmaceuticals & DMF
Microbial limits for non-sterile chemical drugs, API and excipients – new guidelines issued
Microbial limits for non-sterile chemical drugs, active pharmaceutical ingredients (API) and excipients were released in
0
Cisema - Jacky
Tuesday, 28 March 2023
/
Published in
News
,
NMPA Registration in China
,
Pharmaceuticals & DMF
Expedited safety reporting in drug clinical trials – new FAQ issued
Expedited safety reporting in drug clinical trials is a regulatory requirement in China that mandates
0
Cisema - Jacky
Friday, 27 January 2023
/
Published in
News
,
NMPA Registration in China
,
Pharmaceuticals & DMF
China drug standards draft measures have been published by the NMPA
China drug standards draft measures have recently been released by the National Medical Products Administration
0
Cisema - Jacky
Thursday, 29 December 2022
/
Published in
News
,
NMPA Registration in China
,
Pharmaceuticals & DMF
Drug recalls in China now have revised framework and focus
Drug recalls in China now designate market authorization holders (MAH) as the key responsible entity,
1
2
3
4
TOP